Mental Health

Missouri Senate Bill 1682 Proposes Psilocybin Therapy Safe Harbour for Veterans and First Responders

Missouri lawmakers are considering Senate Bill 1682, which would establish a tightly controlled safe harbour for psilocybin-assisted therapy for certain veterans and first responders and broaden the state right-to-try framework to cover Schedule I substances. If enacted, this bill would open a regulated pathway for psilocybin treatment and research in Missouri, signalling a material shift in state controlled-substances policy that mental health providers, hospitals, and emerging psychedelic-therapy businesses would need to track closely.

22 Apr 2026, 19:48senate.mo.govUnited States

European Parliament EMPL Committee Considers Draft Report On Psychosocial Risks And Mental Health At Work

In April 2026, the European Parliament’s Employment Committee discussed a draft own-initiative report on psychosocial risks, stress, and mental health at work, highlighting the growing burden of work-related mental health problems across the EU. Although not yet a binding measure, this signals stronger future EU expectations on employers’ management of psychosocial risks, especially as an anticipated Quality Jobs Act and related labour law reforms take shape.

22 Apr 2026, 18:57europarl.europa.euEuropean Union

European Parliament SANT Committee Draft Opinion on Psychosocial Risks, Stress and Mental Health at Work

The European Parliament’s Public Health Committee has issued a draft opinion proposing stronger EU rules on psychosocial risks, stress, and mental health at work, with detailed amendments that expand employer duties on risk assessment, safe staffing, telework, and return-to-work support. If carried through into the final directive, these provisions would materially raise expectations on organisations’ psychosocial risk management, particularly in health and social care, requiring earlier planning for staffing models, digital management practices, data collection, and occupational health training.

21 Apr 2026, 20:18europarl.europa.euEuropean Union

California Assembly Re-Refers AB 2489 Veterans’ Psychedelic Research Bill to Appropriations

In April 2026, California advanced AB 2489 by re-referring it to the Assembly Appropriations Committee after amending the bill to create a time-limited “California Veterans’ Right to Try Act” enabling state-run clinical trials of psilocybin, ibogaine, and other Schedule I/II substances for veterans. While near-term effects are confined to the state research panel and participating institutions, this signals growing regulatory openness to psychedelic therapies and could shape longer-term compliance expectations for drug developers, clinical sites, and controlled-substance suppliers.

19 Apr 2026, 14:54leginfo.legislature.ca.govUnited States

EU Parliament EMPL Committee To Consider Draft Report on Psychosocial Risks and Mental Health at Work

In April 2026, the European Parliament’s EMPL Committee will formally consider a draft legislative own‑initiative report on psychosocial risks, stress and mental health at work, underscoring the scale of work‑related mental health problems across the EU. This marks a further step toward EU‑level rules on workplace mental health and signals that employers may face more prescriptive obligations around psychosocial risk assessment, work organisation and support measures in the coming years.

13 Apr 2026, 16:31europarl.europa.euEuropean Union

Netherlands House of Representatives Motion to Objectify "Psychosociale Arbeidsbelasting" Definition in Arbowet

The Dutch Parliament is considering a motion to redefine psychosocial workload in the Working Conditions Act using objective and measurable criteria. This shift toward standardized norms would replace subjective employee assessments with predictable compliance requirements for managing workplace stress and mental health risks.

4 Apr 2026, 10:57zoek.officielebekendmakingen.nlNetherlands

Oregon Enacts HB 4069 Requiring Behavioral Health Employer Safety Policies

Oregon has enacted HB 4069, requiring behavioral health service providers contracting with the state to implement formal physical safety and lone-worker protection policies by July 2027. Affected organizations must integrate structural security assessments and specialized safety training into their operational compliance frameworks to maintain eligibility for state-funded contracts.

4 Apr 2026, 10:28olis.oregonlegislature.govUnited States

Iowa Legislative Subcommittee Schedules 1 April 2026 Hearing on HF 978 (Psilocybin Bill)

Iowa is advancing legislation to establish a regulated medical psilocybin framework with licensing for production and therapy potentially starting in July 2026. This development signals a shift toward a state-controlled psychedelics market requiring rigorous compliance with production, testing, and inventory standards.

3 Apr 2026, 18:33legis.iowa.govUnited States

Minnesota HF 4731 Proposes Health Department Report On Lead-Containing Bullets Retained In The Body

Minnesota has introduced legislation requiring a state health department report by January 2027 on the long-term medical and toxicological impacts of lead ammunition fragments. This study is expected to provide the evidentiary basis for future state-level restrictions on lead-based ammunition or enhanced consumer safety warnings.

27 Mar 2026, 07:57revisor.mn.govUnited States

Oregon OHA Initiates Behavioral Health Medicaid Rulemaking and Updates Fee Schedule

Oregon has implemented Medicaid fee schedule adjustments for behavioral health services and proposed stricter certification and physical presence requirements for billing associates. Providers must audit 2026 claims for rate alignment and prepare for enhanced organizational oversight and residency mandates for clinical staff.

27 Mar 2026, 07:50oregon.govUnited States

New Mexico DOH Proposes Rule 7.35.2 NMAC on Medical Psilocybin Producers and Laboratories

New Mexico is establishing a formal regulatory framework for medical psilocybin production and laboratory testing with a public hearing set for April 2026. Prospective operators must prepare for stringent compliance requirements covering traceability, mandatory contaminant testing, and sanitation standards aligned with federal food safety codes.

27 Mar 2026, 06:59nmhealth.orgUnited States

Georgia SB 631 Would Fund FDA-Approved Ibogaine Clinical Trials for Veterans

Georgia introduced legislation to establish state-funded grants for FDA-approved clinical trials using ibogaine for veteran mental health treatments. This initiative reflects a growing state-level shift toward supporting psychedelic research, potentially accelerating the path to market for novel therapeutic substances.

26 Mar 2026, 19:18legis.ga.govUnited States

Minnesota HF4577 Would Establish Psilocybin Therapeutic Use Program and Reschedule Psilocybin

Minnesota has introduced legislation to establish a state-regulated therapeutic psilocybin program and reschedule the substance to Schedule IV by 2027. This proposal creates a structured pathway for medical psychedelic access, requiring stakeholders to navigate rigorous state-level cultivation, testing, and clinical administration standards.

26 Mar 2026, 19:06revisor.mn.govUnited States

Iowa Senate Subcommittee Schedules Hearing On HF 978 Medical Psilocybin Framework

Iowa is advancing legislation to establish a regulated medical psilocybin market, with licensing for production and testing facilities proposed to begin in July 2026. Prospective operators must prepare for rigorous cultivation standards, mandatory potency testing, and strict labeling requirements to mitigate compliance and recall risks.

19 Mar 2026, 19:21legis.iowa.govUnited States

Minnesota House Committee Advances Psilocybin Therapeutic Use Bill Reclassifying Psilocybin/Psilocin (H.F. 2906)

Minnesota is advancing legislation to create a regulated psilocybin therapeutic framework and reclassify psilocybin and psilocin as Schedule IV substances. This transition signals a shift toward medicalized psychedelic markets, requiring businesses to prepare for stringent licensing, product testing, and clinical oversight standards.

18 Mar 2026, 16:25house.mn.govUnited States

Poland Labour Protection Council Adopts Resolutions on State Labour Inspectorate 2026 Programme and Workers’ Mental Health

Poland has finalized the 2026 labor inspection priorities with a new formal emphasis on managing workplace mental health and psychosocial risks. Employers should proactively review stress and burnout prevention strategies to align with heightened regulatory scrutiny and upcoming enforcement cycles.

12 Mar 2026, 14:52rop.sejm.gov.plPoland

California Assembly Introduces AB 2489 Veterans’ Right To Try Act For Psychedelic Research

California introduced legislation in early 2026 to establish an expedited state-level approval pathway for clinical research involving psilocybin and ibogaine. This move signals a shift toward state-led oversight of controlled substance trials, offering pharmaceutical developers a potential route to accelerate development timelines for psychedelic therapies.

12 Mar 2026, 09:16leginfo.legislature.ca.govUnited States

UNCTAD Publishes Summary of Parallel Event on Safe Products for All Consumers

UNCTAD is advancing a global initiative to establish formal principles for consumer product safety, targeting enforcement gaps in e-commerce and emerging technologies. Companies should anticipate more stringent cross-border regulatory alignment and increased liability for online marketplaces as jurisdictions move to harmonize safety standards and recall effectiveness.

11 Mar 2026, 16:26docs.un.orgGlobal

European Environment Agency Publishes Briefing On Pollution And Mental Health

The European Environment Agency has published a briefing linking environmental pollution and exposure to chemicals like lead and endocrine disruptors to increased risks of mental health disorders. This evidence reinforces the strategic shift toward One Health policy and signals that mental health impacts may increasingly justify stricter chemical restrictions and environmental standards.

11 Mar 2026, 12:54eea.europa.euEuropean Union

European Commission Launches Action Plan Against Cyberbullying

The European Commission has launched a non-binding Action Plan Against Cyberbullying to harmonize victim support and national prevention strategies across the EU. While non-legislative, the plan signals a shift toward standardized digital safety expectations and increases pressure on platforms to adopt proactive protection measures.

13 Feb 2026, 07:12commission.europa.euEuropean Union